Themis Medicare withdraws proposed preferential warrant issue
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 0.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Themis Medicare has withdrawn its proposed preferential issue of 45,95,795 convertible equity warrants to a promoter group entity at Rs. 102.87 per warrant. Originally approved on Feb 25, 2026, the issue aimed to meet working capital needs, which have now been arranged through other means. The company will also withdraw its in-principal approval applications from BSE and NSE. Management states no adverse impact on financials or operations.
No equity dilution now; working capital needs met via other routes. No adverse impact stated by management.